Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review
- PMID: 7882549
- DOI: 10.1159/000171464
Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review
Abstract
Cytokines, particularly the proinflammatory cytokines, whose role and natural regulation in inflammatory bowel disease are reviewed here, are produced by many cell types, including immune cells. Cytokines function as important hormones of the immune system, and many act both regionally and systemically via specific receptors. The demonstration of increased circulating and mucosal levels of proinflammatory (and other) cytokines (and receptors) in active inflammatory bowel disease does not by itself constitute any proof as to the primary involvement of these mediators. However, they may contribute significantly to disease manifestations, and specific therapeutic intervention at the cytokine or cytokine receptor level may show up to be clinically most relevant. This is underscored by the increasing evidence that proven therapies of inflammatory bowel disease to a great extent seem to function through cytokine modulation.
Similar articles
-
Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.Dan Med Bull. 2011 Dec;58(12):B4360. Dan Med Bull. 2011. PMID: 22142578
-
Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update.Expert Rev Clin Immunol. 2013 Jan;9(1):77-92. doi: 10.1586/eci.12.91. Expert Rev Clin Immunol. 2013. PMID: 23256766 Review.
-
[Chronic inflammatory bowel disease: Crohn's disease and ulcerative colitis].J Pharm Belg. 2010 Mar;(1):1-9. J Pharm Belg. 2010. PMID: 20432590 Review. French.
-
[Inflammatory bowel disease].Praxis (Bern 1994). 2013 Aug 21;102(17):1046-52. doi: 10.1024/1661-8157/a001380. Praxis (Bern 1994). 2013. PMID: 23965717 Review. German.
-
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease.Dig Liver Dis. 2011 Jan;43(1):1-20. doi: 10.1016/j.dld.2010.07.010. Epub 2010 Sep 16. Dig Liver Dis. 2011. PMID: 20843756
Cited by
-
Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study.Gut. 2003 Sep;52(9):1286-90. doi: 10.1136/gut.52.9.1286. Gut. 2003. PMID: 12912859 Free PMC article. Clinical Trial.
-
Molecular Networking and Bioassay-Guided Preparation and Separation of Active Extract and Constituents from Vicia tenuifolia Roth.Antioxidants (Basel). 2023 Oct 18;12(10):1876. doi: 10.3390/antiox12101876. Antioxidants (Basel). 2023. PMID: 37891955 Free PMC article.
-
Post-liver transplant Crohn's disease: graft tolerance but not self-tolerance?Dig Dis Sci. 2002 Mar;47(3):522-7. doi: 10.1023/a:1017951632444. Dig Dis Sci. 2002. PMID: 11911336
-
Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug.Molecules. 2008 Feb 1;13(2):230-54. doi: 10.3390/molecules13020230. Molecules. 2008. PMID: 18305415 Free PMC article. Review.
-
A simple filter-paper technique allows detection of mucosal cytokine levels in vivo in ulcerative colitis. Interleukin-1 and interleukin-1-receptor antagonist.Dig Dis Sci. 1996 Sep;41(9):1775-9. doi: 10.1007/BF02088744. Dig Dis Sci. 1996. PMID: 8794793 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical